Analyst upgrades:

• Citigroup upgraded Brightpoint (NASDAQ: CELL) to Buy from Hold on expectations global handset units will trough in 2009, leading to a higher multiple for the stock. Citi raised its target on shares to $9 from $6.50.
• FBR Capital upgraded Rosetta Resources (NASDAQ: ROSE) to Outperform from Market Perform on valuation and believes drilling results in Q3 and Q4 should serve as near-term catalysts. The firm raised its target on shares to $15.
• Piper Jaffray upgraded Echelon (NASDAQ: ELON) to Neutral from Underweight following the company's contract announcement with Duke Energy (NYSE: DUK). The firm raised its target on shares to $10 from $6.
• Smith & Nephew (NYSE: SNN) was upgraded to Equal Weight from Underweight at Morgan Stanley.
• Schawk (NYSE: SGK) was upgraded to Neutral from Underperform at Baird.
• Alpha Natural (NYSE: ANR) was upgraded to Outperform from Market Perform at BMO Capital.

• Argus upgraded CBRL Group (NASDAQ: CBRL) to Buy from Hold as it believes increased efficiency at Cracker Barrel will help to boost restaurant traffic and same-store sales. The firm has a $33 target on shares.
  
• Citigroup upgraded shares of Eli Lilly (NYSE: LLY) to Buy from Hold on expectations the company's blood-thinning drug Effient is on track for a Q2 U.S. launch. The firm raised its price target on shares to $41 from $36.
  
• Needham upgraded Intel (NASDAQ: INTC) to Buy from Hold after recent channel checks suggested Intel's PC OEM orders are tracking better than expected. The firm expects Intel to keep prices and product mix stable, enabling margins to recover in Q2. Needham has an $18 target on INTC shares.
• SEI Investments (NASDAQ: SEIC) was upgraded to Outperform from Market Perform at Keefe Bruyette.
  
• Consolidated Edison (NYSE: ED) was raised at Jefferies to Buy from Hold.
  
• Taleo (NASDAQ: TLEO) was lifted to Outperform from Perform at Oppenheimer.

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Acuity Brands Inc. (NYSE: AYI) beat second-quarter estimates on increased productivity and new products.
• Advanced Micro Devices (NYSE: AMD) cut its outlook and announced job cuts.
• Alcoa Inc. (NYSE: AA) missed first-quarter earnings estimates but beat revenue expectations.
• Circuit City Stores Inc. (NYSE: CC) surprised Wall Street by posting a second-quarter profit.
• Dell Inc.'s (NASDAQ: DELL) rosy 2008 forecast is based on cost cuts, overseas growth, share buybacks.
• DuPont & Co. (NYSE: DD) raised its first-quarter outlook on strength in agriculture and emerging markets.
• Eastman Chemical Co. (NYSE: EMN) raised its first-quarter guidance on strong sales and higher prices.
• EXFO Electro-Optical Engineering (NASDAQ: EXFO) beat estimates and announced an acquisition.
• Foundry Networks Inc. (NASDAQ: FDRY) slashed its first-quarter outlook, blaming the weak economy.
• Genentech Inc. (NYSE: DNA) beat first-quarter earnings estimates, but not revenue expectations.
• General Electric Co. (NYSE: GE) missed earnings expectations and lowered its guidance.
• Novellus Systems Inc. (NASDAQ: NVLS) trimmed its first-quarter earnings and revenue forecasts.
• Progressive Corp. (NYSE: PGR) beat estimates though first-quarter profits fell due to lower premiums.
• Rite Aid Corp. (NYSE: RAD) swung to a loss in the fourth quarter on acquisition costs and a tax charge.

Schawk, Inc. (NYSE: SGK) provides brand management services to clients in a variety of businesses. While the company just posted record operating income in FY 2007, it must also restate 2006 income, and faced flat or declining sales in numerous business segments. Income from continuing operations in 4Q 2007 was $0.24, the same as 4Q 2006. 4Q 2007 sales rose less than 1%. The company was particularly hard hit by the writers' strike in Hollywood. Its entertainment accounts unit posted an 18% drop in sales due to fewer ad pages produced.

The company kept a very tight rein on administrative expenses. The company has taken a defensive position, choosing to decrease capital expenditures and reduce interest expense while trying to develop more rigorous internal controls for recognizing revenue. CEO David Schawk remains optimistic the company will have all financial accounting weaknesses under control by the end of 2008. He remains optimistic that the company will show gains in income, sales, and profitability in 2008. The majority of Schawk's clients are in the consumer product packaging unit. Regardless of unfavorable or unstable economic conditions, those accounts will continue to require services.

The stock is currently trading under $15, and may be one patient value investors want to take a look at.